A. Trentalange
发表
Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide for the treatment of HIV in adults
G. di Perri,
A. Calcagno,
S. Bonora,
2016,
Expert opinion on pharmacotherapy.
G. di Perri,
A. Calcagno,
G. Muccioli,
2020,
Pharmaceuticals.
G. di Perri,
A. Calcagno,
S. Bonora,
2019,
Expert review of clinical pharmacology.
G. di Perri,
A. Calcagno,
A. Boghi,
2019,
Journal of NeuroVirology.
C. Atzori,
A. Calcagno,
V. Ghisetti,
2016,
Antiviral therapy.
G. di Perri,
A. Calcagno,
I. Motta,
2021,
International journal of antimicrobial agents.
T. Lupia,
F. D. De Rosa,
R. Cavallo,
2021,
Internal and Emergency Medicine.
G. Marchetti,
G. di Perri,
A. Calcagno,
2022,
British journal of clinical pharmacology.
A. Calcagno,
V. Ghisetti,
S. Audagnotto,
2015,
Antiviral therapy.
Raúl Tabarés Gutiérrez,
Samit R. Joshi,
H. Jessen,
2016,
Journal of the International AIDS Society.
Samit R. Joshi,
Charlene A Flash,
Thomas Lengauer,
2014
.
D. Roccatello,
S. Sciascia,
G. di Perri,
2020,
Thrombosis Research.
G. di Perri,
A. Calcagno,
A. D’Avolio,
2015,
The Journal of antimicrobial chemotherapy.
G. Nunnari,
G. di Perri,
A. Calcagno,
2018,
Brain Imaging and Behavior.
T. Lupia,
F. D. De Rosa,
R. Cavallo,
2021,
Journal of Clinical Medicine.
F. Patti,
G. di Perri,
A. Calcagno,
2015,
Therapeutic drug monitoring.
G. di Perri,
A. Calcagno,
A. D’Avolio,
2014,
Antiviral Research.
A. Calcagno,
A. D’Avolio,
M. Tettoni,
2013
.